Huber RM - Search Results

1

Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer.

Huber RM, Reck M, Gosse H, von Pawel J, Mezger J, Saal JG, Kleinschmidt R, Steppert C, Steppling H. Huber RM, et al. Eur Respir J. 2006 Jun;27(6):1183-9. doi: 10.1183/09031936.06.00015605. Epub 2006 Feb 15. Eur Respir J. 2006. PMID: 16481389 Free article. Clinical Trial.

2

[Lung cancer].

Huber RM. Huber RM. Internist (Berl). 2006 Jun;47(6):611-20; quiz 621. doi: 10.1007/s00108-006-1581-3. Internist (Berl). 2006. PMID: 16767476 Review. German.

3

Reduced expression of Bax in small cell lung cancer cells is not sufficient to induce cisplatin-resistance.

Biagosch J, Huber RM, Bergner A. Biagosch J, et al. Among authors: huber rm. Eur J Med Res. 2010 Oct 25;15(10):448-51. doi: 10.1186/2047-783x-15-10-448. Eur J Med Res. 2010. PMID: 21156403 Free PMC article.

4

[Molecular genetic tests in advanced non-small cell lung cancer: practical relevance].

Sebastian M, Niederle N, Thomas M, Reck M, Schmittel A, Fischer B, Overbeck T, Gröschel A, Deppermann M, Pirker R, Huber RM, Eberhardt W, Griesinger F. Sebastian M, et al. Among authors: huber rm. Dtsch Med Wochenschr. 2014 Oct;139(41):2096-100. doi: 10.1055/s-0034-1387294. Epub 2014 Sep 30. Dtsch Med Wochenschr. 2014. PMID: 25268213 Review. German. No abstract available.

5

Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?

Watermann I, Schmitt B, Stellmacher F, Müller J, Gaber R, Kugler Ch, Reinmuth N, Huber RM, Thomas M, Zabel P, Rabe KF, Jonigk D, Warth A, Vollmer E, Reck M, Goldmann T. Watermann I, et al. Among authors: huber rm. Diagn Pathol. 2015 Jul 28;10:130. doi: 10.1186/s13000-015-0362-5. Diagn Pathol. 2015. PMID: 26215852 Free PMC article.

6

Biological markers in lung cancer: A clinician's perspective.

Tufman A, Huber RM. Tufman A, et al. Among authors: huber rm. Cancer Biomark. 2010;6(3-4):123-35. doi: 10.3233/CBM-2009-0124. Cancer Biomark. 2010. PMID: 20660959 Review.

7

Stent flexibility: an essential feature in the treatment of dynamic airway collapse.

Hautmann H, Huber RM. Hautmann H, et al. Among authors: huber rm. Eur Respir J. 1996 Mar;9(3):609-11. doi: 10.1183/09031936.96.09030609. Eur Respir J. 1996. PMID: 8730026 Free article.

8

Theophylline improves acute mountain sickness.

Fischer R, Lang SM, Steiner U, Toepfer M, Hautmann H, Pongratz H, Huber RM. Fischer R, et al. Among authors: huber rm. Eur Respir J. 2000 Jan;15(1):123-7. doi: 10.1183/09031936.00.15112300. Eur Respir J. 2000. PMID: 10678632 Free article. Clinical Trial.

9

Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.

Lang SM, Stratakis DF, Freudling A, Ebelt K, Oduncu F, Hautmann H, Huber RM. Lang SM, et al. Among authors: huber rm. Eur J Med Res. 2000 Aug 18;5(8):341-6. Eur J Med Res. 2000. PMID: 10958767

10

Molecular oncology--perspectives in lung cancer.

Huber RM, Stratakis DF. Huber RM, et al. Lung Cancer. 2004 Aug;45 Suppl 2:S209-13. doi: 10.1016/j.lungcan.2004.07.973. Lung Cancer. 2004. PMID: 15552801 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters